Literature DB >> 30538406

Multiple Gastrointestinal Cancers in a Single Patient-a Rare Clinical Entity.

Manish Sahni1,2, Ashish Goel3, Pankaj Pande3, Kapil Kumar3.   

Abstract

Multiple gastrointestinal cancers in a single patient is a rare entity. In our study, we are showing the clinical presentation and management of these patients. A fifty-nine-year-old asthenic male (already treated case of metachronous colorectal cancer in 2008 and 2011) presented with complaints of generalized weakness and fatigue. Strong family history was present with two of his first-degree relatives having diagnosed with gastrointestinal cancer at the age < 50 years with one of them having stomach carcinoma and another with GEJ tumors. On evaluation, upper GI endoscopy revealed growth at cardia and endoscopic biopsy revealed adenocarcinoma. Radiological evaluation with PET-CT scan revealed proximal stomach growth with regional lymphadenopathy. Patient was optimized for surgery and underwent D2 total gastrectomy, distal pancreatectomy and splenectomy with Roux-en-Y oesophago-jejunal anastomosis. Pathological stage revealed pT4N2M0, moderately differentiated adenocarcinoma of proximal stomach, both distal and proximal cut margins negative for tumor, LVI present with no perineural invasion, and 5/18 lymph nodes dissected were positive for malignancy. Genetic testing needs to be considered in this patient (modified Bethesda guidelines and IGCLC criteria). Familial gastric cancer are of two types: (a) hereditary diffuse gastric cancer syndrome, (b) familial intestinal type gastric cancer. Approximately 5% of patients have germ-line mutations-AD LYNCH syndrome, hereditary breast-ovarian cancer, and polyposis and non-polyposis syndrome. Once diagnosed in localized advanced stage, the best treatment is R0 resection though overall prognosis in these patients is very poor. So it is rationale to find such families with elevated risk and to do active surveillance for early diagnosis and providing prophylactic gastrectomies to them as it has proven to be beneficial in hereditary form of gastric cancer.

Entities:  

Keywords:  HDGS; MSI; Multiple gastrointestinal tract cancer

Year:  2018        PMID: 30538406      PMCID: PMC6265184          DOI: 10.1007/s13193-018-0770-6

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  6 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.

Authors:  D G Huntsman; F Carneiro; F R Lewis; P M MacLeod; A Hayashi; K G Monaghan; R Maung; R Seruca; C E Jackson; C Caldas
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

3.  Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome.

Authors:  M Aarnio; R Salovaara; L A Aaltonen; J P Mecklin; H J Järvinen
Journal:  Int J Cancer       Date:  1997-10-21       Impact factor: 7.396

4.  Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome.

Authors:  Sean Garrean; Justin Hering; Abdul Saied; Jigna Jani; N Joseph Espat
Journal:  Am Surg       Date:  2008-01       Impact factor: 0.688

5.  CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.

Authors:  Jeffrey A Norton; Christine M Ham; Jacques Van Dam; R Brooke Jeffrey; Teri A Longacre; David G Huntsman; Nicki Chun; Allison W Kurian; James M Ford
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

6.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Authors:  Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

  6 in total
  2 in total

1.  A 66-Year-Old Man Presenting with Port-Site Metastatic Gastric Adenocarcinoma 4 Years After Laparoscopic Resection of a Rectal Adenocarcinoma.

Authors:  Riyadh Hakami; Elham Alzahrani; Ahmed Binjaloud; Sulaiman Alshammari; Turki Alshammari; Amany A Fathaddin; Mohammed Ayesh Zayed; Maha-Hamadien Abdulla; Omar Al-Obeed
Journal:  Am J Case Rep       Date:  2022-05-04

Review 2.  Diet-Derived Phytochemicals Targeting Colon Cancer Stem Cells and Microbiota in Colorectal Cancer.

Authors:  Kumar Ganesan; Muthukumaran Jayachandran; Baojun Xu
Journal:  Int J Mol Sci       Date:  2020-06-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.